Ads
related to: drugmaker eli lilly- Press Releases
Find Press Releases
and News for Lilly.
- Lilly Recognitions
Leaders in D&I, R&D, and
Social Impact & Employee Benefits
- About Lilly
Find How Lilly's Purpose Has Never
Been More Important.
- Our Impact
Learn About How We Responsibly
Grow Our Business.
- Press Releases
Search results
Eli Lilly and Company (LLY) Is a Trending Stock: Facts to Know Before Betting on It
Zacks via Yahoo Finance· 3 days agoEli Lilly (LLY) has recently been on Zacks.com's list of the most searched stocks. Therefore, you...
Costco, Eli Lilly Near New Highs; That Doesn't Scare Mutual Funds
Investor's Business Daily· 1 day agoLilly Stock Near Record Highs IBD Leaderboard drug stock Eli Lilly is in a buy zone up to 833.35 of...
Could Eli Lilly Be the Next to Join the Trillion-Dollar Club?
Motley Fool via Yahoo Finance· 2 days agoSo these waiting-in-the-wings candidates could drive future growth if all goes smoothly. And, as...
Eli Lilly beefs up plan to expand manufacturing for popular drugs Zepbound, Mounjaro
Wyoming Tribune-Eagle· 6 days agoEli Lilly will spend more than $5 billion to expand an Indiana manufacturing site and eventually...
Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential Aristocrats in Disguise: 3...
InvestorPlace· 6 hours agoAlthough there is no hard-and-fast rule about what constitutes a blue-chip stock, they all tend to...
Millions of Americans need drugs like Ozempic: Will it bankrupt the health care system?
Medical Xpress· 3 hours agoAn April 24 letter from Vermont Sen. Bernie Sanders to the CEO of Novo Nordisk began with heartfelt...
Goldman Sees Obesity-Drug Market Growing to $130 Billion by 2030
Bloomberg via Yahoo Finance· 7 hours ago(Bloomberg) -- Goldman Sachs Group Inc. sees growing potential for the global market for weight-loss...
AstraZeneca CEO Has No Plans to Retire as He Seeks to Nearly Double Sales by 2030
The Wall Street Journal· 2 hours agoAstraZeneca’s longest-serving chief executive, Pascal Soriot, has no plans to step down for now as...
3 High-Flying Stocks That Could Soar Even More
Motley Fool via Yahoo Finance· 6 days agoGiven all that, it looks like Vertex Pharmaceuticals isn't finished delivering above-average returns. The biotech still has plenty of upside left. Should...
Ozempic-Maker Novo Nordisk Sues Pharmacies And Weight Loss Clinics For Allegedly Selling Impure...
Forbes· 1 day agoNovo Nordisk has filed nine lawsuits against medical spas, wellness clinics and pharmacies for...
Ad
related to: drugmaker eli lilly